The Regulatory Framework: MoCRA's Biennial Renewal Mandate
The Modernization of Cosmetics Regulation Act of 2022 (MoCRA) fundamentally altered the compliance landscape for cosmetic manufacturers, processors, and their responsible persons. Among its most operationally significant provisions is the requirement, codified in the facility registration and product listing sections of the Federal Food, Drug, and Cosmetic Act as amended by MoCRA, that facility registrations be renewed on a biennial basis. Unlike a one-time regulatory filing, cosmetic facility registration under MoCRA is a recurring obligation that companies must build into their long-term compliance calendars, not a task to be revisited only when a lapse triggers a problem.
For companies that completed initial registration in 2024, the 2026 biennial cycle represents the first true test of whether their internal compliance infrastructure can sustain recurring regulatory obligations without manual intervention or last-minute scrambling. The FDA has signaled that it intends to treat the renewal window seriously, and its recent technical updates to the Cosmetics Direct portal make clear that registration status will now be far more visible and trackable than in the initial rollout period.
What's Changing in Cosmetics Direct for 2026
FDA has introduced new fields within Cosmetics Direct designed to display registration status and upcoming renewal dates directly within a facility's account. This is a meaningful shift from the earlier iteration of the portal, which offered limited visibility into where a facility stood in its compliance lifecycle.
Key implications of these updates include:
- Increased transparency for FDA reviewers. Status fields make it easier for the agency to identify lapsed, delinquent, or inactive registrations during inspections or targeted compliance sweeps.
- Self-monitoring capability for regulated entities. Facilities and their responsible persons can now more readily confirm whether a registration remains active, reducing reliance on internal tracking spreadsheets alone.
- Data alignment with FDA's broader enforcement priorities. As the agency continues to build out its cosmetics compliance infrastructure, registration status data will likely feed into risk-based inspection targeting.
While these portal enhancements are procedural in nature, they carry substantive consequences. A registration that quietly lapses is no longer merely an administrative oversight buried in an email inbox; it is now a visible data point that FDA staff can identify with minimal effort.
Who Must Renew and When
Under MoCRA, owners and operators of facilities that manufacture or process cosmetic products for distribution in the United States must renew their facility registration during the biennial renewal window, which runs from October 1 through December 31 of each even-numbered year. The 2026 cycle therefore falls within that same fourth-quarter window, and facilities should not assume that renewal deadlines mirror their original registration date.
Companies should confirm renewal obligations apply to them by assessing:
- Whether the entity qualifies as a "facility" under MoCRA's definition, encompassing establishments that manufacture or process cosmetic products distributed in the U.S., subject to the statute's exemptions.
- Whether any applicable small business exemption previously relied upon remains valid, given that exemption status can change based on revenue thresholds or product categories.
- Whether contract manufacturers, private label arrangements, or co-packing relationships have shifted responsibility for registration between parties since the last filing.
Responsible persons should not assume that a contract manufacturer or third-party filer has automatically handled renewal; the underlying legal obligation remains with the facility owner or operator, and reliance on an outside party without verification creates unnecessary exposure.
Practical Compliance Steps for the 2026 Cycle
Given the added visibility FDA now has into registration status, a proactive and documented approach is essential. We recommend the following steps well in advance of the fourth-quarter 2026 window:
- Conduct a registration audit. Confirm current registration status directly in Cosmetics Direct using the new status fields, rather than relying on internal records that may be outdated.
- Reconcile facility and product listing data. Renewal is an opportune moment to verify that product listings remain accurate and reflect any formulation, packaging, or manufacturing site changes since the last submission.
- Assign clear internal ownership. Designate a specific individual or team responsible for monitoring renewal deadlines, ideally with calendar reminders set well before the October 1 opening of the renewal window.
- Document the renewal process. Maintain internal records evidencing timely renewal submission, which can serve as valuable documentation in the event of an FDA inquiry or inspection.
- Review responsible person designations. Confirm that the responsible person identified in the registration remains accurate and reflects current organizational structure.
Enforcement Risk and Strategic Considerations
FDA has generally approached MoCRA implementation with a measured, education-first posture, consistent with its handling of other major regulatory transitions. However, the enhanced portal functionality suggests the agency is moving toward a more data-driven compliance monitoring model. Facilities should not interpret prior enforcement discretion as a permanent policy.
A lapsed or delinquent registration carries tangible risk. Beyond the potential for FDA to flag noncompliant facilities during inspections, an inaccurate registration status may complicate commercial relationships, particularly where retailers, distributors, or international partners require confirmation of current regulatory standing as a condition of doing business.
From a governance perspective, boards and senior compliance officers should treat MoCRA renewal management with the same rigor applied to other recurring regulatory filings, such as annual corporate reports or environmental permits. Embedding renewal tracking within broader enterprise compliance systems, rather than treating it as an isolated cosmetics-specific task, reduces the likelihood of inadvertent lapse.
Building a Sustainable Compliance Program
The 2026 renewal cycle offers companies an opportunity to move beyond reactive, deadline-driven compliance and toward a durable system capable of managing recurring MoCRA obligations indefinitely. This includes integrating registration renewal into standard operating procedures, training relevant personnel on portal navigation, and establishing escalation protocols if a renewal deadline approaches without confirmed completion.
Companies with complex supply chains, multiple manufacturing sites, or private label arrangements should consider periodic legal review of registration and listing accuracy, ensuring that organizational changes are promptly reflected in FDA filings.
Key Takeaways
The FDA's updates to Cosmetics Direct are a clear signal that biennial renewal compliance is entering a more scrutinized phase. Facilities that treat the 2026 renewal cycle as a routine formality risk falling behind an increasingly transparent and monitored regulatory system. Proactive governance, clear internal ownership, and early engagement with the renewal window remain the most effective safeguards against compliance gaps and potential enforcement exposure.